Plasminogen activator inhibitor type 2 in breast cancer.

The serine protease urokinase plasminogen activator (uPA) is causally involved in cancer invasion and metastasis. Activity of this protease in vivo is controlled principally by two inhibitors, one of which is plasminogen activator inhibitor type 2 (PAI-2). In this study, we show that PAI-2 levels we...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Duggan, C., Kennedy, S., Kramer, M. D., Barnes, C., Elvin, P., McDermott, E., O'Higgins, N., Duffy, M. J.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1997
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2228003/
https://ncbi.nlm.nih.gov/pubmed/9303361
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires